首页 | 本学科首页   官方微博 | 高级检索  
检索        

克拉霉素为基础的三联方案根除幽门螺杆菌的疗效研究
引用本文:张庆芳,沙卫红,王启仪.克拉霉素为基础的三联方案根除幽门螺杆菌的疗效研究[J].胃肠病学,2012,17(8):480-482.
作者姓名:张庆芳  沙卫红  王启仪
作者单位:广东省医学科学院 广东省人民医院消化内科 510180
摘    要:克拉霉素是根除幽门螺杆菌(Hpylori)感染的有效药物,以克拉霉素为基础的三联方案根除Hpylori在临床上广泛应用。目的:评估克拉霉素为基础的三联方案根除日.pylori的疗效。方法:133例Hpylori感染患者随机分为3组,A组:埃索美拉唑20mgbid+克拉霉素0.5gbid+阿莫西林1gbid,疗程7d;B组:埃索美拉唑20mgbid+克拉霉素0.5gbid+左氧氟沙星0.5gqd,疗程7d;C组:埃索美拉唑20mgbid+克拉霉素0.5gbid+呋喃唑酮0.1gtid,疗程7d。治疗结束后4~8周复查”C-尿素呼气试验和快速尿素酶试验以评估根除疗效。结果:128例患者按方案完成治疗。A、B、C组按意向治疗(11-r)分析日.pylori根除率分别为84.4%、77.3%、75.0%,按方案(PP)分析分别为88.4%、79,1%、78.6%。A组的11Tr和PP根除率高于B组和C组,但差异无统计学意义(P〉0.05)。结论:克拉霉素联合质子泵抑制剂(PPI)和阿莫西林7d疗法仍为有效的Hpylori感染根除方案。

关 键 词:螺杆菌  幽门  根除率  克拉霉素  质子泵抑制剂  治疗

Therapeutic Effect of Clarithromycin-based Triple Therapy for Helicobacter pylori Eradication
ZHANG Qingfang , SHA Weihong , WANG Qiyi.Therapeutic Effect of Clarithromycin-based Triple Therapy for Helicobacter pylori Eradication[J].Chinese Journal of Gastroenterology,2012,17(8):480-482.
Authors:ZHANG Qingfang  SHA Weihong  WANG Qiyi
Institution:.Department of Gastroenterology and Hepatology,Guangdong General Hospital,Guangdong Academy of Medical Sciences,Guangzhou(510180)
Abstract:Clarithromycin is effective for eradication of Helicobacter pylori ( H. pylori) infection. Clarithromycin- based triple therapy has been widely used in clinical practice. Aims: To assess the efficacy of clarithromycin-based triple therapy for H. pylori eradication. Methods: A total of 133 11. pylori-infected patients were enrolled and randomly assigned into three groups. Patients in group A were given esomeprazole 20 mg bid + elarithromyein 0.5 g bid + amoxicillin 1 g bid for 7 days. Patients in group B were given esomeprazole 20 mg bid + clarithromycin 0.5 g bid + levofloxacin 0.5 g qd for 7 days. Patients in group C were given esomeprazole 20 mg bid + clarithromycin 0.5 g bid + furazolidone 0.1 g tid for 7 days. At 4-8 weeks after a course of treatment, H. pylori eradication was assessed by 13 C-urea breath test and rapid urease test. Results: A total of 128 patients completed the study. H. pylori eradication rates by intention-to-treat (ITY) analysis in group A, B and C were 84.4%, 77.3% and 75.0% , respectively; by per-protocol (PP) analysis were 88.4% , 79.1% and 78.6% , respectively. The eradication rate in group A was higher than that in group B and C by both ITF and PP analysis, but no statistically significant differences were found among the three groups ( t9 〉 0.05 ). Conclusions : The proton pump inhibitor (PPI)-clarithromycin-amoxicillin 7-day triple therapy is still an effective treatment for eradication of H. pylori infection.
Keywords:Helicobacter pylori  Eradication Rate  Clarithromycin  Proton Pump Inhibitors  Therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号